Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.29 USD | -0.90% | -7.92% | -26.83% |
09-04 | Jefferies Initiates Nextracker at Hold With $46 Price Target | MT |
08-02 | UBS Adjusts Price Target on Nextracker to $67 From $65, Maintains Buy Rating | MT |
Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Profitability | ||||||
Return on Assets | 15.82 | 13.21 | 4.34 | 8.72 | 18.63 | |
Return on Total Capital | 31.24 | 28.43 | 8.53 | 18.62 | 40.94 | |
Return On Equity % | 40.06 | 36.19 | 10.64 | 24.61 | 67.2 | |
Return on Common Equity | 40.06 | 36.19 | 22.48 | -0.07 | -28.96 | |
Margin Analysis | ||||||
Gross Profit Margin % | 18.18 | 19.4 | 10.09 | 15.09 | 27.67 | |
SG&A Margin | 4.73 | 5.06 | 4.59 | 5.01 | 7.34 | |
EBITDA Margin % | 14.25 | 14.67 | 5.29 | 9.18 | 23.66 | |
EBITA Margin % | 13.98 | 14.52 | 5.1 | 9 | 23.5 | |
EBIT Margin % | 12.71 | 13.26 | 4.52 | 8.94 | 23.49 | |
Income From Continuing Operations Margin % | 10.1 | 10.4 | 3.49 | 6.38 | 19.85 | |
Net Income Margin % | 10.1 | 10.4 | 3.49 | 6.25 | 12.25 | |
Net Avail. For Common Margin % | 10.1 | 10.4 | 3.49 | 0.06 | 12.25 | |
Normalized Net Income Margin | 7.95 | 8.26 | 2.79 | 5.48 | 7.6 | |
Levered Free Cash Flow Margin | 18.29 | 4.42 | -11.06 | 6.06 | 9.57 | |
Unlevered Free Cash Flow Margin | 18.29 | 4.42 | -11.06 | 6.12 | 9.92 | |
Asset Turnover | ||||||
Asset Turnover | 1.99 | 1.59 | 1.54 | 1.56 | 1.27 | |
Fixed Assets Turnover | 161.46 | 129.21 | 137.98 | 170.03 | 134.34 | |
Receivables Turnover (Average Receivables) | 5.7 | 4.87 | 4 | 3.69 | 3.71 | |
Inventory Turnover (Average Inventory) | 22.12 | 13.23 | 10.21 | 10.41 | 10.64 | |
Short Term Liquidity | ||||||
Current Ratio | 0.83 | 1.49 | 1.51 | 1.72 | 1.98 | |
Quick Ratio | 0.62 | 1.17 | 1.03 | 1.38 | 1.45 | |
Operating Cash Flow to Current Liabilities | 0.66 | 0.24 | -0.31 | 0.21 | 0.48 | |
Days Sales Outstanding (Average Receivables) | 64.16 | 74.95 | 91.27 | 98.81 | 98.75 | |
Days Outstanding Inventory (Average Inventory) | 16.54 | 27.59 | 35.74 | 35.06 | 34.39 | |
Average Days Payable Outstanding | 51.72 | 75.25 | 65 | 55.17 | 65.31 | |
Cash Conversion Cycle (Average Days) | 28.98 | 27.29 | 62 | 78.69 | 67.83 | |
Long Term Solvency | ||||||
Total Debt/Equity | 2.34 | 0.99 | 0.9 | 31.05 | 16.64 | |
Total Debt / Total Capital | 2.28 | 0.98 | 0.89 | 23.69 | 14.27 | |
LT Debt/Equity | 1.73 | 0.66 | 0.54 | 30.66 | 15.88 | |
Long-Term Debt / Total Capital | 1.69 | 0.65 | 0.53 | 23.39 | 13.61 | |
Total Liabilities / Total Assets | 62.68 | 48.23 | 50.74 | 65.85 | 60.61 | |
EBIT / Interest Expense | - | 7.93K | 1.94K | 92.75 | 42.48 | |
EBITDA / Interest Expense | - | 8.85K | 2.32K | 96.32 | 42.96 | |
(EBITDA - Capex) / Interest Expense | - | 8.73K | 2.14K | 94.59 | 42.52 | |
Total Debt / EBITDA | 0.03 | 0.03 | 0.06 | 0.85 | 0.28 | |
Net Debt / EBITDA | 0.01 | -1.05 | -0.31 | 0.12 | -0.52 | |
Total Debt / (EBITDA - Capex) | 0.03 | 0.03 | 0.06 | 0.87 | 0.28 | |
Net Debt / (EBITDA - Capex) | 0.01 | -1.07 | -0.34 | 0.12 | -0.53 | |
Growth Over Prior Year | ||||||
Total Revenues, 1 Yr. Growth % | 77.27 | 2.08 | 21.91 | 30.5 | 31.42 | |
Gross Profit, 1 Yr. Growth % | 276.6 | 8.96 | -36.62 | 95.18 | 141.01 | |
EBITDA, 1 Yr. Growth % | 745.81 | 5.09 | -56.06 | 94.05 | 238.86 | |
EBITA, 1 Yr. Growth % | 887.57 | 5.96 | -57.15 | 96.09 | 243.24 | |
EBIT, 1 Yr. Growth % | 12.66K | 6.46 | -58.43 | 115.62 | 245.51 | |
Earnings From Cont. Operations, 1 Yr. Growth % | -7.54K | 5.15 | -59.06 | 138.31 | 308.97 | |
Net Income, 1 Yr. Growth % | -7.54K | 5.15 | -59.06 | 133.51 | 157.59 | |
Normalized Net Income, 1 Yr. Growth % | 19.5K | 6.11 | -58.8 | 113.57 | 82.48 | |
Diluted EPS Before Extra, 1 Yr. Growth % | - | - | - | - | 13.59K | |
Accounts Receivable, 1 Yr. Growth % | 18.62 | 20.37 | 71.77 | 23.53 | 37.02 | |
Inventory, 1 Yr. Growth % | 140.42 | 38.06 | 103.86 | -19.83 | 46.13 | |
Net Property, Plant and Equip., 1 Yr. Growth % | 71.35 | 2 | 26.08 | -10.1 | 151.38 | |
Total Assets, 1 Yr. Growth % | 11.07 | 42.28 | 15.47 | 39.56 | 77.42 | |
Tangible Book Value, 1 Yr. Growth % | -210.79 | -401.87 | -250.48 | 1.13K | -120.77 | |
Common Equity, 1 Yr. Growth % | -35.7 | 97.37 | -100.67 | 101K | -131.24 | |
Cash From Operations, 1 Yr. Growth % | -1.83K | -60.88 | -256.05 | -173.19 | 298.42 | |
Capital Expenditures, 1 Yr. Growth % | -34.43 | 48.82 | 140.24 | -46.21 | 93.53 | |
Levered Free Cash Flow, 1 Yr. Growth % | - | -75.35 | -405.22 | -175.28 | 107.69 | |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | -75.34 | -405.11 | -176.04 | 113.07 | |
Compound Annual Growth Rate Over Two Years | ||||||
Total Revenues, 2 Yr. CAGR % | - | 34.52 | 11.55 | 26.13 | 30.96 | |
Gross Profit, 2 Yr. CAGR % | - | 102.57 | -16.9 | 11.22 | 116.89 | |
EBITDA, 2 Yr. CAGR % | - | 198.13 | -32.04 | -0.2 | 156.36 | |
EBITA, 2 Yr. CAGR % | - | 223.48 | -32.62 | -0.67 | 159.37 | |
EBIT, 2 Yr. CAGR % | - | 1.07K | -33.47 | 3.56 | 172.87 | |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | 784.34 | -34.39 | -1.22 | 212.19 | |
Net Income, 2 Yr. CAGR % | - | 784.34 | -34.39 | -2.22 | 145.25 | |
Normalized Net Income, 2 Yr. CAGR % | - | 1.34K | -33.88 | 2.71 | 97.37 | |
Accounts Receivable, 2 Yr. CAGR % | - | 19.49 | 43.79 | 45.67 | 30.1 | |
Inventory, 2 Yr. CAGR % | - | 82.19 | 67.77 | 27.84 | 8.23 | |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | 32.2 | 13.4 | 6.46 | 50.33 | |
Total Assets, 2 Yr. CAGR % | - | 25.71 | 28.18 | 26.94 | 57.35 | |
Tangible Book Value, 2 Yr. CAGR % | - | 82.87 | 113.13 | 331.02 | 60.15 | |
Common Equity, 2 Yr. CAGR % |